Prescient Therapeutics LimitedASX: PTX

Prescient Share Purchase Plan Investor Presentation

· Issued by Prescient Therapeutics Limited via ASX

Filed with ASX ·

Suite 2, Level 11, 385 Bourke Street, Melbourne VIC 300 Australia Prescient Therapeutics Limited T - +61 3 9692 7222 | F - +613 9077 9233 | W - ptxtherapeutics.com ABN 56 006 569 106 SPP Presentation Join the CEO of PTX James McDonnell for a live and interactive shareholder...

View Attachment

6ix hasn’t read this filing yet.

Prescient Therapeutics Limited on 6ix

In the deck

Earlier from Prescient Therapeutics

Later from Prescient Therapeutics

All Prescient Therapeutics news releases